Clinical Trial Update: Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating individualized therapy for adenocarcinoma at the esophagogastric junction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction

Snippet

Sponsor: Technical University of Munich | Conditions: Adenocarcinoma of the Esophagogastric Junction | Phase 2 | Status: COMPLETED